Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;38(1):123-7.
doi: 10.1007/s00264-013-2078-z. Epub 2013 Sep 5.

Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis

Affiliations

Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis

Patrick W O'Donnell et al. Int Orthop. 2014 Jan.

Abstract

Purpose: The objective of this study was to evaluate the early results of a custom non-fluted diaphyseal press-fit stem for use with the global modular replacement system (GMRS) tumour prosthesis and the early complications associated with this implant.

Methods: A total of 53 patients (54 implants) were identified from a prospective database where a custom non-fluted diaphyseal press-fit stem was used as part of the reconstruction of the limb. All patients had a minimum of 22 months of follow-up.

Results: The rates of stem revision for any reason were calculated. The median follow-up was 36 months (range 22-85 months). Aseptic loosening was not observed in any patient.

Conclusions: At early term follow-up, an uncemented non-fluted stem used with the GMRS tumour endoprosthesis provides a stable bone-prosthesis interface with no evidence of aseptic loosening.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Radiographs of the non-fluted stem inserted after proximal tibial resection as part of knee reconstruction
Fig. 2
Fig. 2
Radiographs of the proximal femoral resection and reconstruction using the custom non-fluted stem inserted as part of hip reconstruction
Fig. 3
Fig. 3
Radiographs of the custom non-fluted stem inserted after distal femoral resection as part of knee reconstruction

Similar articles

Cited by

References

    1. Sampo M, Koivikko M, Taskinen M, Kallio P, Kivioja A, Tarkkanen M, Böhling T. Incidence, epidemiology and treatment results of osteosarcoma in Finland—a nationwide population-based study. Acta Oncol. 2011;50(8):1206–1214. doi: 10.3109/0284186X.2011.615339. - DOI - PubMed
    1. Sampo MM, Tarkkanen M, Kivioja AH, Taskinen MH, Sankila R, Böhling TO. Osteosarcoma in Finland from 1971 through 1990: a nationwide study of epidemiology and outcome. Acta Orthop. 2008;79(6):861–866. doi: 10.1080/17453670810016966. - DOI - PubMed
    1. D’Adamo DR. Appraising the current role of chemotherapy for the treatment of sarcoma. Semin Oncol. 2011;38(Suppl 3):S19–S29. doi: 10.1053/j.seminoncol.2011.09.004. - DOI - PubMed
    1. Asavamongkolkul A, Eckardt JJ, Eilber FR, Dorey FJ, Ward WG, Kelly CM, Wirganowicz PZ, Kabo JM. Endoprosthetic reconstruction for malignant upper extremity tumors. Clin Orthop Relat Res. 1999;360:207–220. doi: 10.1097/00003086-199903000-00025. - DOI - PubMed
    1. Morgan HD, Cizik AM, Leopold SS, Hawkins DS, Conrad EU., 3rd Survival of tumor megaprostheses replacements about the knee. Clin Orthop Relat Res. 2006;450:39–45. doi: 10.1097/01.blo.0000229330.14029.0d. - DOI - PubMed

MeSH terms

LinkOut - more resources